Abbott Laboratories Embarks on Major Transformation with Exact Sciences Acquisition.

Abbott Laboratories is repositioning its business after ongoing challenges in its Nutrition segment. The company plans to acquire Exact Sciences to expand into oncology diagnostics, alongside a sharper focus on diabetes and cardiovascular products. The acquisition aims to add a new growth leg and rebalance the business away from the challenged Nutrition segment. Integration risks and potential rewards are significant, with Abbott seeking to maintain overall business stability while capitalizing on a higher-margin growth opportunity.